Next Article in Journal
Is TRPA1 Burning Down TRPV1 as Druggable Target for the Treatment of Chronic Pain?
Next Article in Special Issue
The Chemokine CXCL16 Is a New Biomarker for Lymph Node Analysis of Colon Cancer Outcome
Previous Article in Journal
A Novel Reporter Mouse Uncovers Endogenous Brn3b Expression
Previous Article in Special Issue
Chemokines in COPD: From Implication to Therapeutic Use
Open AccessReview

Chemokine Signaling in Chemotherapy-Induced Neuropathic Pain

1
Dompé Farmaceutici SpA, Via Campo di Pile,67100 L’Aquila, Italy
2
Department of Life, Health and Environmental Sciences, University of L’Aquila, 67100 L’Aquila, Italy
3
Sbarro Institute for Cancer Research and Molecular Medicine and Center for Biotechnology, Temple University, Philadelphia, PA 19122, USA
*
Authors to whom correspondence should be addressed.
Int. J. Mol. Sci. 2019, 20(12), 2904; https://doi.org/10.3390/ijms20122904
Received: 10 May 2019 / Revised: 10 June 2019 / Accepted: 12 June 2019 / Published: 14 June 2019
(This article belongs to the Special Issue Chemokines in Cancer and Inflammatory Diseases)
Chemotherapy-induced peripheral neuropathy (CIPN) is a side effect of chemotherapics such as taxanes, vinca alkaloids, and platinum compounds. In recent years, several reports have indicated the involvement of different molecular mechanisms in CIPN. The pathways described so far are diverse and target various components of the peripheral Nervous System (PNS). Among the contributors to neuropathic pain, inflammation has been indicated as a powerful driver of CIPN. Several pieces of evidence have demonstrated a chemotherapy-induced increase in peripheral pro-inflammatory cytokines and a strong correlation with peripheral neuropathy. At present, there are not adequate strategies to prevent CIPN, although there are drugs for treating CIPN, such as duloxetine, that have displayed a moderate effect on CIPN. In this review, we focus on the players involved in CIPN with a particular emphasis on chemokine signaling. View Full-Text
Keywords: chemotherapy; peripheral nervous system; central nervous system; inflammatory mediators; cytokines; chemokines chemotherapy; peripheral nervous system; central nervous system; inflammatory mediators; cytokines; chemokines
Show Figures

Figure 1

MDPI and ACS Style

Brandolini, L.; d’Angelo, M.; Antonosante, A.; Cimini, A.; Allegretti, M. Chemokine Signaling in Chemotherapy-Induced Neuropathic Pain. Int. J. Mol. Sci. 2019, 20, 2904.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop